Citation Details
Short interfering RNA (siRNA) targeting the Lyn kinase induces apoptosis in primary, and drug-resistant, BCR-ABL1(+) leukemia cells
| Authors | |
| In | |
| Cells used in publication | HL-60 (ATCC) Blood/Immune Cells Cell Lines Species: human Tissue Origin: blood K-562 (ATCC) Blood/Immune Cells Cell Lines Species: human Tissue Origin: blood T cell, stim., human Human stimulated T cells Blood/Immune Cells Primary Cells Species: human Tissue Origin: blood CD34+ cell, human Human CD34+ hematopoietic progenitor cells Stem Cells Primary Cells Species: human Tissue Origin: blood LAMA-84 Blood/Immune Cells Cell Lines Species: human Tissue Origin: blood M-07e Blood/Immune Cells Cell Lines Species: human Tissue Origin: blood EM2 Blood/Immune Cells Cell Lines Species: human EM3 Blood/Immune Cells Cell Lines Species: human |
| Substrate | siRNA |
| Applications | |
| Topics | |
| Research Areas | |
| Relevant Products |
Research Field
Leukemias that express the oncoprotein BCR-ABL1 are resistant to apoptotic stimuli, and are relatively insensitive to chemotherapy. However, they show an increased dependence on Lyn signaling for survival, which provides the basis for rational treatment. Lyn is a kinase that interacts with BCR-ABL1 in signaling complexes.
Nucleofection Experiments
Lyn siRNA was transfected into different human primary cells (CD34+ cells, leukemic blasts) and cell lines (K562, HL-60, EM2, EM3, LAMA84, Mo7e). In all cells that express BCR-ABL1 (leukemic blasts from patients; K562, EM2, EM3, LAMA84) Lyn knock-down led to apoptosis, all cells not expressing BCR-ABL1 (normal CD34+ cells; Mo7e) did not go into apoptosis upon Lyn knock-down.
In a rescue experiment for the apoptosis phenotype K562 cells were cotransfected with siRNA to the 3’UTR of Lyn mRNA together with a Lyn expression construct lacking the 3’UTR.

